Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial.
Int J Cancer
; 132(7): 1581-91, 2013 Apr 01.
Article
in En
| MEDLINE
| ID: mdl-22948952
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Peptide Fragments
/
Polyethylene Glycols
/
Colorectal Neoplasms
/
Tumor Suppressor Protein p53
/
Interferon-gamma
/
Interferon-alpha
/
Cancer Vaccines
/
Liver Neoplasms
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Cancer
Year:
2013
Type:
Article
Affiliation country:
Netherlands